Talking Biotech with Dr. Kevin Folta
Drug Discovery in the Synapse - Derek Small
Sponsors in this episode
No sponsor reads found in this episode's notes.
Host-read ads that the notes don't mention can't be found this way.
Show notes
In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Derek Small, co-founder and CEO of Syndeoo, focusing on the increasing prevalence of neurological disorders and the challenges in developing effective therapies. They discuss the importance of synaptic function in mental health and neurodegenerative diseases, the innovative Boost platform for drug development, and the potential of event-driven pharmacology. The conversation highlights the hope for new treatments in the pipeline for conditions like depression and Alzheimer's disease.
From the show's RSS feed.